Key Global Manufacturing Partners Within Naked’s Wholly Owned Subsidiary, Bendon Limited Participate to Form Strategic Alliance in Advance of New Growth Plan

SYDNEY, AU / ACCESSWIRE / March 28, 2019 / Naked Brand Group Limited (NASDAQ: NAKD) (“Naked” or the “Company”), a global leader in intimate apparel and swimwear, has signed a definitive agreement for a private placement of restricted common stock and warrants for aggregate gross proceeds of approximately $3.9 million with accredited investors led by Los Angeles-based family office Acuitas Capital and including Naked CEO, Justin Davis-Rice. In conjunction with the private placement, Naked completed a $5.35 million debt restructuring in exchange for common stock at $0.40 per share with key global manufacturing and strategic partners within the company’s wholly owned brand, Bendon Limited.

The ordinary shares were sold at a per share price of $0.255 pursuant to a subscription agreement with each investor. Investors who participated in the private placement also received a warrant to purchase 100% of the number of ordinary shares for which it subscribed. Naked intends to use the proceeds from the private placement for working capital, general corporate purposes and the company’s new strategic alliance with Bendon Limited’s key global manufacturing partners.

“This new strategic alliance with Bendon Limited’s key global manufacturing partners reflects the stability of our 15-year relationship and the confidence they see in our current business model,” said Justin Davis-Rice, Chief Executive Officer of Naked Brand Group Limited. “Our balance sheet now has an infusion of capital which will allow us to execute on our growth strategy and positions Naked with a clear line of sight to a resumption of revenue growth in 2019. I participated in this financing to demonstrate my confidence in the company and look forward to providing further updates on our new strategic direction in the weeks to come,” concluded Davis-Rice.

About the Transaction

The private placement financing includes transactions with multiple parties on varying terms, at per share purchase prices ranging from $0.255 to $0.40. In the aggregate, we expect to issue to the investors ordinary shares (or pre-funded warrants in lieu thereof) and warrants to purchase ordinary shares. We advise all shareholders to review the full details of transaction in the report on Form 6-K to be filed with the SEC. or the investor relations section of the Company’s website here.

About Naked Brand Group Limited:

Naked Brand Group Limited (NASDAQ: NAKD) is a leading intimate apparel and swimwear company with a diverse portfolio of brands. The company designs, manufactures and markets a portfolio of 11 company-owned and licensed brands, catering to a broad cross-section of consumers and market segments. Brands include Naked, Bendon, Bendon Man, Davenport, Fayreform, Hickory, Lovable, Pleasure State, Heidi Klum Intimates, Heidi Klum Man, Heidi Klum Swim. Naked Brand Group Limited products are available in 44 countries worldwide through 6,000 retail doors, a growing network of E-commerce sites and 61 company-owned Bendon retail and outlet stores in Australia and New Zealand. Brands are distributed through premier department stores, specialty stores, independent boutiques and third-party e-commerce sites globally, including Macy’s, Nordstrom, Saks Fifth Avenue, Harrods, Selfridges, Amazon and ASOS among others. For more information please visit www.nakedbrands.com.

Forward-Looking Statements:

This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. Such statements may be, but need not be, identified by words such as “may,” “believe,” “anticipate,” “could,” “should,” “intend,” “plan,” “will,” “aim(s),” “can,” “would,” “expect(s),” “estimate(s),” “project(s),” “forecast(s)”, “positioned,” “approximately,” “potential,” “goal,” “pro forma,” “strategy,” “outlook” and similar expressions. Examples of forward-looking statements include, among other things, statements regarding future financial performance, future growth in our business, trends in our industry, product innovation and operational expansion. All such forward-looking statements are based on management’s current beliefs, expectations and assumptions, and are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results expressed or implied in this communication. Among the key factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are the following: our ability to integrate the operations of Bendon Limited and Naked Brand Group Inc.; the risk that the projected value creation and efficiencies from the transaction with Bendon Limited and Naked Brand Group Inc. will not be realized; difficulties in maintaining customer, supplier, employee, operational and strategic relationships; the possibility that a robust market for our shares may not develop; our ability to raise additional financing; our ability to anticipate consumer preferences; and the other risks and uncertainties set forth under “Risk Factors” in our Annual Report on Form 20-F for the fiscal year ended January 31, 2018, as amended. Further, investors should keep in mind that our revenue and profits can fluctuate materially depending on many factors. Accordingly, our revenue and profits in any particular fiscal period may not be indicative of future results. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise, except as required by law.

Investor Contact:

Joel Primus
Naked Brand Group Limited
joel@thenakedshop.com

Chris Tyson
MZ North America
chris.tyson@mzgroup.us
949-491-8235

SOURCE: Naked Brand Group Limited

ReleaseID: 540381

NEW YORK, NY / ACCESSWIRE / March 28, 2019 / Gaucho Group Holdings, Inc. (OTCQB: VINO), a collection of luxury assets, real estate holdings and premium wines in Argentina, today announced the Fall/Winter Collection debut for its designer fashion and accessories label, Gaucho – Buenos Aires (GauchoBuenosAires.com), which was showcased to fashion industry media at Argentine fashion week’s Designers Buenos Aires on March 18, 2019. Founded by entrepreneur Scott Mathis and headed up by Argentine designers Santiago Gallo and Carmen Vils, Gaucho – Buenos Aires blends the quality of a bygone era with a sophisticated, modern, global outlook. The brand’s beautifully handcrafted clothing and accessories herald the birth of Argentina’s finest designer label.

Gaucho – Buenos Aires embodies the spirit of Argentina – its grand history, its folklore and its revival as a global center of luxury. Inspired by the sophisticated elegance of the great European maisons, Gaucho – Buenos Aires is also rooted in the traditions of native, nomadic culture. With its ambitious couture, ready-to-wear and high-street fashion offering, this is the brand in which Argentine luxury finds its contemporary expression.

“We are very excited to see Gaucho – Buenos Aires on its way to what we hope will become the top luxury brand in Argentina,” said Scott Mathis, Gaucho Group Holding’s founder, chairman and CEO. “Our Fall/Winter collection’s debut at Tattersall De Palermo further solidified the reputation of uniqueness and quality of our brand, our designers, and our products. Since the event, our social media follower base has grown significantly and continues to grow daily. For this, we thank all those who have shared news of our arrival to the world fashion scene on their social platforms, including social media influencer Neels Visser, our designers Santiago Gallo and Carmen Vils, and numerous Argentine and International celebrities that attended the launch.”

Established in Buenos Aires, the Gaucho story is one of impeccable timing. Once dubbed the Paris of South America for its exquisite Belle Epoque style, the city is thriving again and entering a new golden age. The time is ripe for Buenos Aires to align itself with Milan, New York, Paris and London as a global fashion capital, and Gaucho – Buenos Aires will be its bold ambassador. The devaluation of the Argentine Peso has actually proven to draw a record number of tourists to the country, most of whom are looking to take home their own piece of Buenos Aires. Gaucho – Buenos Aires looks to fill this void.

Gaucho Group Holdings’ goal is to reintroduce the world to the grandeurs of the city’s elegant past, intertwined with an altogether deeper cultural connection: the strength, honor and integrity of the Gaucho. Seen in the intricate stitching of handmade leather, or the exquisite workmanship of an embossed belt buckle, “Gaucho” style is a world-renowned symbol of Argentine craftsmanship. Blending the quality of a bygone era with a sophisticated, modern, global outlook, the brand’s beautifully handcrafted clothing and accessories herald the birth of Argentina’s finest designer label.

Please visit GauchoBuenosAires.com today to sign up for insider fashion news, behind-the-brand stories, exclusive invitations, and special access to wait lists and pre-ordering.

About Gaucho Group Holdings, Inc.

For more than ten years, Gaucho Group Holdings’ mission has been to source and develop opportunities in Argentina’s undervalued luxury real estate and consumer marketplace. With our proprietary collection of wine, hospitality, fashion brands, and real estate holdings as a foundation, we seek to build our luxury brand ALGODON®, one of prestige, distinction and elegance. We begin with a focus on the quality and reputation of our award-wining wines, Algodon Fine Wines, which serve as our ambassador for our luxury lifestyle properties and other real estate assets. As we continue to produce the ultra-fine wines for which we have become recognized, we expect that our reputation for quality will continue to grow and accordingly increase the value of our brand and real estate holdings. Gaucho Group Holdings’ luxury assets are currently concentrated in Argentina, which we believe represents one of the most undervalued investment sectors in the world today. For more information, please visit www.gauchogroupholdings.com.

Cautionary Note Regarding Forward-Looking Statements

The information discussed in this press release includes ”forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 (the ”Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the ”Exchange Act”). All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. These forward-looking statements are identified by their use of terms and phrases such as ”may,” ”expect,” ”estimate,” ”project,” ”plan,” ” believe,” ”intend,” ”achievable,” ”anticipate,” ”will,” ”continue,” ” potential,” ”should,” ”could,” and similar terms and phrases. Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. Among these risks are those set forth in a Form 10-K filed on March 30, 2018. It is important that each person reviewing this release understand the significant risks attendant to the operations of Gaucho Group Holdings. Gaucho Group Holdings disclaims any obligation to update any forward-looking statement made herein.

For press inquiries, please contact Rick Stear, Director of Marketing

SOURCE: Algodon Group, Inc.

ReleaseID: 540363

SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 28, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression, social anxiety disorder and other central nervous system (CNS) diseases and disorders with high unmet need, today announced that the Australian Patent Office (IP Australia) has granted a patent related to methods of treating depression with AV-101, VistaGen’s oral drug candidate in Phase 2 development for treatment of major depressive disorder (MDD). The newly issued Australian Patent No. 2014209466 is a counterpart to U.S. Patent No. 9,993,453 granted to VistaGen by the U.S. Patent and Trademark Office in June 2018, and will not expire until at least 2034.

About AV-101

VistaGen’s AV-101 (4-Cl-KYN) is an investigational, oral NMDA receptor glycine site antagonist with potential to be a treatment for multiple CNS indications with high unmet need. AV-101 is currently in Phase 2 clinical development in the U.S. for MDD and in a first-step target engagement study in healthy volunteer U.S. military Veterans for suicidal ideation. The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for development of AV-101 as both a potential adjunctive treatment for MDD and as a non-opioid treatment for neuropathic pain.

About Major Depressive Disorder (MDD)

According to the World Health Organization (WHO), MDD affects nearly 300 million people of all ages globally and is the leading cause of disability worldwide. Individuals with depression, including MDD, experience continuous suffering from the serious, biologically-based disease which has a significant negative impact on all aspects of life, including quality of life. While current antidepressants are widely used for treatment, large-scale studies have suggested that the drug-treated MDD market is substantially underserved by current medications.

About VistaGen

VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need. VistaGen’s CNS pipeline includes three drug candidates, AV-101, PH10, and PH94B, with potential for at-home use, rapid-onset therapeutic benefits and exceptional safety. Each CNS drug candidate in VistaGen’s pipeline is either currently in or has completed Phase 2 clinical development. PH10 nasal spray is a potential first-in-class CNS neuroactive steroid with rapid-onset antidepressant effects observed at microgram doses and without systemic exposure. PH10 is in Phase 2 development for MDD. PH94B nasal spray is a potential first-in-class CNS neuroactive steroid with rapid-onset effects observed at microgram doses and without systemic exposure. Phase 2 and pilot Phase 3 development of PH94B for social anxiety disorder (SAD) has been completed successfully, and PH94B is now being prepared for pivotal Phase 3 development as an on-demand PRN treatment for SAD.

For more information, please visit www.vistagen.com and connect with VistaGen on Twitter, LinkedIn and Facebook.

Forward-Looking Statements

This release contains various statements concerning VistaGen’s future expectations, plans and prospects, including without limitation, our expectations regarding development and commercialization of our drug candidates, including AV-101 for MDD, neuropathic pain and suicidal ideation, PH94B for SAD, and PH10 for MDD, as well as our intellectual property and commercial protection of our drug candidates, all of which constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are neither promises nor guarantees of future performance and are subject to a variety of risks and uncertainties, many of which are beyond our control, and may cause actual results to differ materially from those contemplated in these forward-looking statements. Among these risks is the possibility that (i) we may encounter unexpected adverse events in patients during our clinical development of any product candidate that cause us to discontinue further development, (ii) we may not be able to successfully demonstrate the safety and efficacy of our product candidates at each stage of clinical development, (iii) success in preclinical studies or in early-stage clinical trials may not be repeated or observed in ongoing or future studies, and ongoing or future preclinical and clinical results may not support further development of, or be sufficient to gain regulatory approval to market AV-101, PH94B, and/or PH10, (iv) decisions or actions of regulatory agencies may negatively affect the progress of, and our ability to proceed with, further clinical studies or to obtain marketing approval for our drug candidates, (v) we may not be able to obtain or maintain adequate intellectual property protection and other forms of marketing and data exclusivity for our product candidates, (vi) we may not have access to or be able to secure substantial additional capital to support our operations, including our ongoing clinical development activities, and (vii) we may encounter technical and other unexpected hurdles in the manufacturing and development of any of our product candidates. Certain other risks are more fully discussed in the section entitled “Risk Factors” in our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in our other filings with the Securities and Exchange Commission (SEC). Our SEC filings are available on the SEC’s website at www.sec.gov. In addition, any forward-looking statements represent our views only as of the issuance of this release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements.

Company Contact
Mark A. McPartland
VistaGen Therapeutics Inc.
Phone: +1 (650) 577-3600
Email: IR@vistagen.com

Investor Contact
Valter Pinto / Allison Soss
KCSA Strategic Communications
Phone: +1 (212) 896-1254/+1 (212) 896-1267
Email: VistaGen@KCSA.com

Media Contact
Caitlin Kasunich / Lisa Lipson
KCSA Strategic Communications
Phone: +1 (212) 896-1241/+1 (508) 843-6428
Email: VistaGen@KCSA.com

SOURCE: VistaGen Therapeutics, Inc.

ReleaseID: 540410

ATLANTA, GA / ACCESSWIRE / March 28, 2019 / Findit, Inc., a Nevada Corporation trading under the stock symbol (OTC PINK: FDIT), explains the importance of using Findit to post content daily on Findit and share it through social media outlets to heighten awareness of your Vitamin Shop, Nutrition Store, or other retail location that offers CBD related products for sale.

Findit is a social media content management platform that offers free online marketing tools as well as paid for services to CBD retailers. Sellers of CBD whether online or a physical store can increase exposure by posting and sharing through Findit. Many retailers are now selling CBD products but many people do not know where to go to purchase them. By creating an account on Findit, retailers can create content within their own Findit site to let locals know where they are and what CBD products they carry. This is a tangible way to increase brand awareness while reaching local customers.

Each store or retailer that sells CBD products can purchase a Findit Vanity Keyword URL for $7.95. The URLs can contain the name of the town, cbd and or store name.

By purchasing a Findit Vanity URL, it gives Findit’s search engine a distinct place to index you as well as Google, Yahoo and Bing. Indexing in outside search engines is often dependent on the content you include inside your Findit site. When stores have an account within Findit, they provide search engines additional pages to index over their competitors while providing members and non members on Findit content that they can see and share.

Today, many people are learning about CBD for the first time. The more stores selling CBD Hemp Oil and explaining the product in Findit, the more educated consumers become and you can be a source of relevant content for search engines as well.

An existing member on Findit is CBD Unlimited, who owns several Vanity Keyword URLs that are linked to their e-commerce website cbdunlimited.com along with being mapped by Google Maps from their Findit pages. By doing this, Google knows where their physical location is as well as their website. Each piece of content that is created in their Findit sites can include a link back to their own website product pages to drive traffic there as well as to their store.

Below are live Findit sites for CBD Unlimited, they have a total of twelve to date. Notice after the forward slash the words or letters. This is the Vanity Keyword URL offered in Findit. It can include the name of a town where your store is located. Within each Findit site, the left side menu is the navigation. Content can be created by the member. Findit also offers content creation as as paid for service.

Findit.com/cbd

Findit.com/cbd-oil

Findit.com/hemp-oil

Here is an overview of what you could do when joining Findit to get your store locations listed in Findit search.

An example would be the ‘Good Nutrition’ store that sells CBD products in Sandy Springs, Georgia. The Sandy Springs Good Nutrition store could purchase findit.com/good-nutrition-sandy-springs or the findit.com/cbd-for-sale-sandy-springs to help improve online presence in search engines and throughout social media for those looking to purchase CBD products in Sandy Springs.

When consumers are looking to purchase a product for the first time, if they don’t yet have a referral for where to go to get the CBD that they want, they will likely turn to the web. Consumers searching for ‘cbd products for sale in sandy springs’ will be more likely to come across your content on Findit or on social media if you have done the following things: reserved a URL on Findit that matches what the consumer is searching for, have created content regularly that is geared around what the consumer is looking to purchase, and are actively having your content seen and shared by more people from Findit to other social networking sites.

Findit is set up to give each store the tools they need to create a single place where any and all information about them can be found easily and understood by the reader. This is the about section on Findit. The about page gives businesses a place for a profile image, a banner image, a mapping feature that has the address, the hours of operation, a phone number and even a place to include a link back to your website. Moreover, Findit also offers businesses looking to promote their CBD products a place to create Right Now Status Updates that can be shared to 80 other social sites. A right now status update can include unlimited text, unlimited photos (which can also include a title and description for improved indexing) a video from Youtube or Vimeo, an audio file where you could describe the benefits of the product, and more.

All of these tools are provided to each member at no cost. Findit does offer paid for services such as the Vanity URL, video production, and marketing campaigns if your business either does not have the time to do their own marketing or wish to utilize our in-house team to develop crafted content using best SEO practices to further help your content index.

Currently, Findit provides online marketing services to CBD Unlimited and over the last several years the marketing campaign has included creating fresh content on a daily basis through right now status updates, website development and SEO, video production and more.

Clark St. Amant of Findit stated, “So many stores that are selling CBD are not separating themselves from other local retailers by marketing online. If you want to become a destination, you want to reach your customers on their mobile devices, on social media, and in search engine results. Yes, placing a sign outside your store saying ‘We Sell CBD’ is important but you are limited to only the people that drive by. Reach the people that are at home that are learning about CBD online by letting them know you are the local authority when it comes to CBD, by reaching them through Findit. By using Findit, you can give consumers all the information they need to know about your business and where it is.”

To sign up your stores on Findit and reserve the Vanity Keyword URLs you need to be indexed in Findit CLICK HERE

To reserve a Prime Package on Findit CLICK HERE

Findit owns the domains listed below and is considering building out a directory to match each domain.

Finditcbd.com

Findithemp.com

Finditweed.com

About Findit. Inc.

Findit, Inc., (OTC Pinksheets FDIT) owns Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increased brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTCPinksheets.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Contact:

Findit, Inc.
Phone 404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 540362

alltemp® documented to be 19.77% more efficient than Chemours’™ Opteon™XP 40 (R-449A) Refrigerant for chilled and frozen food refrigeration

WESTLAKE VILLAGE, CA / ACCESSWIRE / March 28, 2019 / Alltemp, Inc. (OTC PINK: LTMP) (the “Company”), a developer of proprietary, environmentally friendly refrigerant technologies, announced today that recently completed testing, performed by Environmental Testing Laboratory, Inc. (“ETL”), in Dallas, Texas, confirmed that its alltemp® refrigerant is able to greatly reduce energy consumption, when compared to Opteon™ XP 40 (R-449A), the industry leading R-404A replacement refrigerant developed by Chemours™, the $6 billion global chemical spin-off from DuPont.

Alltemp commissioned ETL, an independent third party testing and consulting services provider, to perform an Air Conditioning, Heating and Refrigeration Institute (“AHRI”) 1250 P test (Performance Rating of Walk-in Coolers and Freezers), in accordance with the AHRI protocol, to evaluate the performance of alltemp® in direct comparison with Opteon™ XP 40 (R-449A).

The recent ETL test results indicate that, by removing more heat with less energy consumption, alltemp® is 19.77% more efficient than Opteon™ XP 40 (R-449A) refrigerant, the leading R-404A replacement. According to its product information sheet, Opteon™ XP 40 is “Up to 12% lower energy consumption compared to R-404A/R-507.”

“Third party verification of this performance level is a huge step for us, especially as we reach out to potential customers. The ETL results confirm that alltemp’s® core technology is much more efficient than Opteon™ XP 40, a very good industry leading product, but, in addition to reducing energy operating costs, we believe that alltemp® delivers many attractive competitive advantages, including substantially better GWP benefits.

“Alltemp’s seamless holistic approach can help grocers focus on lowering environmental impact and operational costs, rather than try to squeeze price sensitive consumers. Based on the test results, we can now confidently state that supermarkets are a prime example of an industry that can benefit immediately from our technology,” said William Lopshire, Alltemp CEO.

R404A was introduced, in the mid-1990s, as a replacement for ozone depleting CFCs, including R12 and R502, and, more recently, as a replacement for HCFCs, such as R22. It has become one of the most widely used refrigerants, especially in the supermarket sector, where it has become a dominant, globally, chilled and frozen food refrigerant. It is also used widely in other commercial systems, for industrial refrigeration and cold storage.

Recently, there has been a push to identify alternatives for R-404A because of its particularly high global warming potential (“GWP”) rating, at 3922, which is the highest of all the commonly used refrigerants. R-134a is only 1,430 and R-407F is 1850. Hence leakage of 1 kg of R404A is two to three times worse in terms of global warming impact than other HFC refrigerants and the European Commission has already proposed prohibiting refrigerants with GWP greater than 2500 for servicing and maintaining commercial refrigeration equipment.

For alltemp® sales inquiries, please contact Mark Greenberg at (855) 687-4867, ext 712 or Mark@alltemp.solutions.

About Environmental Testing Laboratory, Inc.

ETL has been providing extensive high quality environmental product testing services since 1974. For further information please go to www.etldallas.com.

About Alltemp, Inc.

Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp®, a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. alltemp®,’s refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. alltemp® refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning (“HVAC”), to refrigeration and foam insulation, to industrial solvents. alltemp® is the ideal solution for replacement R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth’s ozone layer. For further information, please go to alltempsolutions.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995 (the “Act”), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words “plan,” “confident that,” “believe,” “expect,” or “intend to,” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company’s future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company’s actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company’s products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.

Contact:

Alltemp, Inc.
ir@stockcommgroup.com
832-802-8724

SOURCE: Alltemp, Inc.

ReleaseID: 540380

MIAMI, FL / ACCESSWIRE / March 28, 2019 / GH Capital, Inc. (OTCQB: GHHC), a diversified holding company, today announced its signing an advisory agreement with Vitana X, a direct network marketing business primarily focused in Europe.

Bill Bollander, Chief Executive Officer of GH Capital, commented, “We are thrilled to now be working with Vitana X and its management team as they prepare for a U.S. public listing. Vitana X is expected to contribute to our 2019 revenue plan.”

Vitana X is an international wellness company specializing in the development and manufacture of health-promoting products based on DNA analysis. As a pioneer in this industry and a worldwide network of highly qualified experts, it offers its customers extensive opportunities to lead a healthier life.

Vitana X offers comprehensive programs for greater well-being, fitness and health by helping you achieve the desired results and offering exercises that fit your body type. Vitana X wants to support people in their healthy development and be their reliable partner for their full potential. Vitana X comes from two worlds and wants to unite them in the future – science and the challenges of daily life, so that its customers can continue to care for other areas of life without sacrificing a healthy life.

To achieve its goal and as many people as possible, Vitana X uses the most proven and effective form of marketing, Recommendations. The company rewards its satisfied customers as soon as they recommend the products to their friends or family. Thus, in addition to the great product line, all customers also get the opportunity to enjoy their product for free, or use Vitana X as a source of income to become financially independent.

For more information, please visit: http://vitana-x.net.

About GH Capital

GH Capital, Inc. (OTCQB: GHHC) is a diversified holding company offering a range of financial solutions for businesses layered with an advisory platform to assist companies going public. For more information, please visit: http://www.ghcapital-inc.com

Forward-Looking Statements

Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Form 10-K filed on December 28, 2018, for the fiscal year ended September 30, 2018, including but not limited to the discussion under “Risk Factors” therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.

Contact Information

press@ghcapital-inc.us
305-714-9397

SOURCE: GH Capital, Inc.

ReleaseID: 540364

Announces $17 million in new contract awards for 2019

ATLANTA, GA / ACCESSWIRE / March 28, 2019 / Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the ”Company”) today announced preliminary results for the fourth quarter and full year ended December 31, 2018. Revenue for the year ended December 31, 2018 is expected to be $49.5 million compared to $49.8 million in prior year. Net loss attributable to Common Stockholders for the year ended December 31, 2018 is expected to be $1.4 million compared to $3.7 million in prior year.

Mark Duff, Chief Executive Officer, stated, ”Though the results in 2018 did not meet our expectations, we are excited with the changes in the Company over the past several months including the completion of the cleanup phase of the M&EC facility closure and the startup of the GeoMelt technology. In addition, we are beginning to realize a return on our business development strategy as we have been awarded several new projects in March that will further increase our funded backlog and bolster our Services Segment beginning in the second quarter of 2019. These wins, which will be formally signed and announced in the coming weeks, include remediation work in Canada as well as several DOE locations throughout the United States. We expect the total contract value of these awards to collectively be approximately $17 million, be earned in 2019 and include significant out-year potential. We believe these awards are a direct result of the improvements we made last year within our business development organization.”

The Company is in the process of completing the audit of the results for the fourth quarter and full year ended December 31, 2018, which will be separately announced and included in the Company’s Form 10-K to be filed with the Securities & Exchange Commission.

About Perma-Fix Environmental Services

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company’s nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the DOE, the Department of Defense (DOD), and the commercial nuclear industry. The Company’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates three nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide.

Please visit us at http://www.perma-fix.com.

This press release contains ”forward-looking statements” which are based largely on the Company’s expectations and are subject to various business risks and uncertainties, certain of which are beyond the Company’s control. Forward-looking statements generally are identifiable by use of the words such as ”believe”, ”expects”, ”intends”, ”anticipate”, ”plan to”, ”estimates”, ”projects”, and similar expressions. Forward-looking statements include, but are not limited to: revenues and net loss; formally sign contracts from new project awards in the coming weeks; increase our funded backlog and bolster our Services Segment beginning in the second quarter of 2019; the total contract value of these new awards should collectively be approximately $17 million and earned in 2019 and could likely include significant out-year potential; and benefit of the startup of the GeoMelt technology. These forward-looking statements are intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. While the Company believes the expectations reflected in this news release are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this release, including, without limitation, future economic conditions; industry conditions; competitive pressures; our ability to apply, commercialize, and market our new technologies; the government or such other party to a contract granted to us fails to abide by or comply with the contract or to deliver waste as anticipated under the contract; completion of construction projects on a timely basis; regulatory approvals; Congress provides continuing funding for the DOD’s and DOE’s remediation projects; ability to obtain new foreign and domestic remediation contracts; our ability to fund the commercialization of our technology; changes required by the auditors; and the additional factors referred to under ”Risk Factors” and “Special Note Regarding Forward-Looking Statements” of our 2017 Form 10-K and subsequently filed Form 10-Qs during 2018. The Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that bear upon forward-looking statements.

Please visit us on the World Wide Web at http://www.perma-fix.com.

Contacts:

David K. Waldman-US Investor Relations
Crescendo Communications, LLC
(212) 671-1021

Herbert Strauss-European Investor Relations
herbert@eu-ir.com
+43 316 296 316

SOURCE: Perma-Fix Environmental Services, Inc.

ReleaseID: 540392